Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST
Gregory Goldmacher, Anuradha Khilnani, Robert H.I. Andtbacka, Jason J. Luke, F. Stephen Hodi, Aurélien Marabelle, Kevin J. Harrington, Andrea Perrone, Archie Tse, David C. Madoff, Lawrence H. Schwartz
Abstract
3141Background: The approval of intratumoral (IT) immunotherapy for metastatic melanoma and the active development of numerous novel IT drugs have created a need for standardized evaluation of resp...
Topics & Concepts
MedicineImmunotherapyMetastatic melanomaMelanomaOncologySolid tumorInternal medicineCancer researchMedical physicsCancerCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses